AKT1 and non-small cell lung carcinoma: Among these, the PI3K/Akt/mTOR pathway is dysregulated in 50–70% of NSCLC cases and approximately 47% of squamous cell carcinomas (SCCs), as reported by the Cancer Genome Atlas project [8].